Wilmington, DE – Ufovax, a spin-off vaccine company from Scripps Research, announced today that the company has successfully extended its patented one component self-assembling protein nanoparticle (1c-SApNP) vaccine platform technology to a vaccine against the coronavirus SARS-CoV-2. The vaccine prototype features SARS-CoV-2 protein spikes protruding… [Read more]
Archives for March 2020
Uvax Bio
3801 Kennett Pike
Ste. A101, #4482
Wilmington, DE
19807-9998
info@uvaxbio.com